![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, April 01, 2020 9:13:51 PM
In the meanwhile, the stock will continue to trade, largely based on what people believe is happening. While I certainly hope they'll still do the trial with people with psoriasis or other skin diseases, I don't know that we'll be notified that they are. If they have actions on their patents it's doubtful that they'll say so, but people researching the patent sites may find such action is occurring. If I remember correctly, in the other company the CEO would on occasions take phone calls from investors, so news of the calls were discussed.
If in fact positive things are occurring in spite of the lack of news, when the time is right they'll come current, and we all may be pleasently surprised.
Gary
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM